Search and analyze individual stocks with comprehensive metrics
Amrutanjan Health Care Ltd
Fundamental Score
Amrutanjan Health Care Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of AMRUTANJAN across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (16.53%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.45%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (15.52%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Excellent EPS Growth (15.43% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (15.18% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (387.75x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹165.83 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
1 factors identified
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Amrutanjan Health Care Ltd
About AMRUTANJAN
Business Overview
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints, as well as provides sanitary napkins for women. In addition, it operates a pain management center. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Company Details
Key Leadership
Corporate Events
AMRUTANJAN Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Amrutanjan Health Care Ltd (AMRUTANJAN)?
As of 19 Jan 2026, 10:13 am IST, Amrutanjan Health Care Ltd (AMRUTANJAN) is currently trading at ₹610.55. The stock has a market capitalization of ₹1.97K (Cr).
Is AMRUTANJAN share price Overvalued or Undervalued?
AMRUTANJAN is currently trading at a P/E ratio of 34.82x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Amrutanjan Health Care Ltd share price?
Key factors influencing AMRUTANJAN's price include its quarterly earnings growth (Sales Growth: 7.08%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Amrutanjan Health Care Ltd a good stock for long-term investment?
Amrutanjan Health Care Ltd shows a 5-year Profit Growth of 15.18% and an ROE of 16.53%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.01 before investing.
How does Amrutanjan Health Care Ltd compare with its industry peers?
Amrutanjan Health Care Ltd competes with major peers in the Pharmaceuticals. Investors should compare AMRUTANJAN's P/E of 34.82x and ROE of 16.53% against the industry averages to determine its competitive standing.
What is the P/E ratio of AMRUTANJAN and what does it mean?
AMRUTANJAN has a P/E ratio of 34.82x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹35 for every ₹1 of annual earnings.
How is AMRUTANJAN performing according to Bull Run's analysis?
AMRUTANJAN has a Bull Run fundamental score of 60.1/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does AMRUTANJAN belong to?
AMRUTANJAN operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amrutanjan Health Care Ltd.
What is Return on Equity (ROE) and why is it important for AMRUTANJAN?
AMRUTANJAN has an ROE of 16.53%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Amrutanjan Health Care Ltd generates profits from shareholders' equity.
How is AMRUTANJAN's debt-to-equity ratio and what does it indicate?
AMRUTANJAN has a debt-to-equity ratio of 0.01, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is AMRUTANJAN's dividend yield and is it a good dividend stock?
AMRUTANJAN offers a dividend yield of 0.67%, which means you receive ₹0.67 annual dividend for every ₹100 invested.
How has AMRUTANJAN grown over the past 5 years?
AMRUTANJAN has achieved 5-year growth rates of: Sales Growth 11.56%, Profit Growth 15.18%, and EPS Growth 15.43%.
What is the promoter holding in AMRUTANJAN and why does it matter?
Promoters hold 46.52% of AMRUTANJAN shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is AMRUTANJAN's market capitalization category?
AMRUTANJAN has a market capitalization of ₹1974 crores, placing it in the Small-cap category.
How volatile is AMRUTANJAN stock?
AMRUTANJAN has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for AMRUTANJAN?
AMRUTANJAN has a 52-week high of ₹N/A and low of ₹N/A.
What is AMRUTANJAN's operating profit margin trend?
AMRUTANJAN has a 5-year average Operating Profit Margin (OPM) of 15.52%, indicating the company's operational efficiency.
How is AMRUTANJAN's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 7.08% and YoY Profit Growth of 18.31%.
What is the institutional holding pattern in AMRUTANJAN?
AMRUTANJAN has FII holding of 2.38% and DII holding of 12.90%. Significant institutional holding often suggests professional confidence in the stock.